Company Registration No. 9464308 (England and Wales)
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
COMPANY INFORMATION
Directors
Mr D M Farrell
Mr S J Foster
(Appointed 23 December 2022)
Company number
9464308
Registered office
First Floor Premises
14 Woolhall Street
Bury St. Edmunds
Suffolk
IP33 1LA
Auditor
RSM UK Audit LLP
Third Floor
T Bromley
15-17 London Road
Bromley
Kent
BR1 1DE
Business address
First Floor Premises
14 Woolhall Street
Bury St. Edmunds
Suffolk
IP33 1LA
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 14
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 1 -

The directors present the strategic report for the year ended 31 December 2022.

Fair review of the business and future plans

The principal activity of the company is that of a holding investment company. The company had no trading during the year or the prior year. The company has a net asset position of £1,789,990 (2021: £1,789,990) at the year end. The company is expected to continue with the activities at a similar level in the forthcoming year.

As we reflect on 2022, Vita Health Solutions Limited (VHS), the company’s wholly owned subsidiary has delivered strong top-line growth in 2022, driven by full year impact of contracts launched in 2021 plus the the launch of new NHS contracts during the year. This has resulted in a small increase in profit.

Our colleagues have once again demonstrated their commitment to the business, ensuring our propositions continue to lead the market effectively and efficiently, with continued focus on leveraging digital capabilities to support our patients as appropriate. We have invested materially in our People Services Team during 2022, reflecting our commitment to addressing issues on Equality, Diversity and Inclusion which has been positively received by our staff. This focus will continue as we strive to lead the way and ensure that our staff base is reflective of the patients we serve.

Our NHS market unit continues to grow substantially with one new Mental Health NHS contract in the North of England and the successful implementation of a new Dermatology service in North West England. These contracts have performed in line with expectation as the year has progressed. We have continued to reinvest in our Mental Health proposition, expanding ways service users can access the services and ensuring that the clinical pathways are as effective as possible.

The Corporate market unit has also performed well, successfully on-boarding several recognised brands along with enhancing our relationships with well-known private medical insurers. The business model continues to be able to provide virtual alongside face to face pathways and these have been well received from both users and Corporate customers alike.

The Directors of Vita Health Solutions Ltd follow group practice in relation to section 172 compliance. Further details of this can be found in the consolidated group accounts.

Trading results for the wholly owned subsidiary VHS are positive with profit before tax of £2,323,492 compared with £2,178,851 in 2021.

Looking forward, the Directors of the business remain very confident in our ability to continue to grow and deliver results in line with expectation. We have successfully launched another new NHS Mental Health contract in early 2023. We are currently mobilising another NHS Mental Health contract and two additional NHS Dermatology contracts, all of which are due to go live in early 2024. We continue to enhance our MSK proposition and are confident this will lead to further growth.

Principal risks and uncertainties and financial risk management policies and objectives

In common with every other business, the company aims to minimise financial risk. The measures used by the directors to manage this risk include the preparation of profit and cash flow forecasts, regular monitoring of actual performance against these forecasts and ensuring that adequate financing facilities are in place to meet the requirements of the business.

Apart from the risks impacting the wholly owned subsidiary, VHS, which are stated below, there are no specific risks identified impacting this company as it is a holding company.

Vita Health Solutions Limited has a financial risk management objective of ensuring that its’ trading financial requirements are supported rather than hindered by exposure to third party (non-equity) financial instruments. The business continues to have access to additional facilities available through Kingfisher Midco Limited and our ultimate shareholder Archimed SAS (Med I / Med Feeder I) should these be required.

CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 2 -
Credit risk

Credit risk is the risk of financial loss to the company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The company is mainly exposed to credit risk from credit sales. It is group policy to assess the credit risk of new customers before entering contracts. Credit risk also rises from cash and cash equivalents and deposits with banks and financial institutions. For banks and financial institutions, only independently rated parties with minimum rating “A” are used.

Liquidity risk

Liquidity risk arises from the company’s management working capital and the finance charges and principal repayments on its debt instruments. It is a risk that the group will encounter difficulty in meeting its’ financial obligations as they fall due. To achieve this aim, it seeks to maintain cash balances (or agreed facilities) to meet expected requirements for a period of at least 30 days. The Board receives a 12-month rolling cash flow projection monthly as well as daily information regarding cash balances as required.

Operational risk

Operational risk is the risk of direct or indirect loss arising from a wide variety of causes associated with the group’s processes, personnel, technology, and infrastructure, and from external factors other than credit and market risk such as those arising from legal and regulatory requirements and generally accepted standards of corporate behaviour. The governance framework supported by detailed operational procedures manages operational risk to balance the avoidance of financial losses and damage to reputation with overall cost effectiveness and to avoid control procedures that restrict initiative and creativity.

Financial key performance indicators

The directors of Kingfisher Topco Limited manage the group’s operations on a group wide basis. For this reason, the company directors believe that analysis using key performance indicators for the company is not necessary or appropriate for an understanding of the development, performance, or position of Crystal Palace Physio Holdings Limited.

The development, performance, and position of Crystal Palace Physio Holdings Limited is discussed in the group’s report and financial statements which does not comprise part of this report.

The directors have not identified any risks specific to this entity. Group risks have been covered in the consolidated financial statements of Kingfisher Topco Limited.

On behalf of the board

Mr D M Farrell
Director
5 October 2023
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2022.

Principal activities

The principal activity of the company continued to be that of a holding company.

Results and dividends

The results for the year are set out on page 7.

No ordinary dividends were paid (2021: £Nil). The directors do not recommend payment of a final dividend (2021: £Nil).

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr D M Farrell
Mr S J Foster
(Appointed 23 December 2022)
Mr J P Clover
(Resigned 23 December 2022)
Qualifying third party indemnity provisions

The company has made qualifying third party indemnity provisions for the benefit of its directors during the year. These provisions remain in force at the reporting date.

Auditor

The auditor, RSM UK Audit LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Strategic report

Future developments are not disclosed within the Directors' Report as it is instead included within the the Strategic Report on page 1 under s414c(11) of the companies Act 2006.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Mr D M Farrell
Director
5 October 2023
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2022
- 4 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
- 5 -
Opinion

We have audited the financial statements of Crystal Palace Physio Holdings Limited (the 'company') for the year ended 31 December 2022 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

 

Responsibilities of directors

As explained more fully in the directors’ responsibilities statement set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities are instances of non-compliance with laws and regulations. The objectives of our audit are to obtain sufficient appropriate audit evidence regarding compliance with laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, to perform audit procedures to help identify instances of non-compliance with other laws and regulations that may have a material effect on the financial statements, and to respond appropriately to identified or suspected non-compliance with laws and regulations identified during the audit.

In relation to fraud, the objectives of our audit are to identify and assess the risk of material misstatement of the financial statements due to fraud, to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud through designing and implementing appropriate responses and to respond appropriately to fraud or suspected fraud identified during the audit.

However, it is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the entity's operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud.

CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
- 7 -

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, the audit engagement team:

 

As a result of these procedures we consider the most significant laws and regulations that have a direct impact on the financial statements are FRS 102 and the Companies Act 2006. We performed audit procedures to detect non-compliances which may have a material impact on the financial statements which included reviewing financial statement disclosures.

 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities This description forms part of our auditor’s report.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

William Farren FCA
For and on behalf of RSM UK Audit LLP
5 October 2023
Chartered Accountants
Statutory Auditor
Third Floor
T Bromley
15-17 London Road
Bromley
Kent
BR1 1DE
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2022
- 8 -
2022
2021
£
£
Profit before taxation
-
0
-
0
Tax on profit
-
0
-
0
Profit for the financial year
-
0
-
0
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2022
31 December 2022
- 9 -
2022
2021
Notes
£
£
£
£
Fixed assets
Investments
5
1,736,278
1,736,278
Current assets
Debtors
7
53,712
53,712
Net current assets
53,712
53,712
Net assets
1,789,990
1,789,990
Capital and reserves
Called up share capital
8
1,083
1,083
Share premium account
56,309
56,309
Capital redemption reserve
21
21
Profit and loss reserves
1,732,577
1,732,577
Total equity
1,789,990
1,789,990
The financial statements were approved by the board of directors and authorised for issue on 5 October 2023 and are signed on its behalf by:
Mr D M Farrell
Director
Company Registration No. 9464308
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2022
- 10 -
Share capital
Share premium account
Capital redemption reserve
Profit and loss reserves
Total
£
£
£
£
£
Balance at 1 January 2021
1,083
56,309
21
1,732,577
1,789,990
Year ended 31 December 2021:
Profit and total comprehensive income for the year
-
-
-
-
0
-
0
Balance at 31 December 2021
1,083
56,309
21
1,732,577
1,789,990
Year ended 31 December 2022:
Profit and total comprehensive income for the year
-
-
-
-
0
-
0
Balance at 31 December 2022
1,083
56,309
21
1,732,577
1,789,990
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
- 11 -
1
Accounting policies
Company information

Crystal Palace Physio Holdings Limited is a private company limited by shares incorporated in England and Wales. The registered office is First Floor Premises, 14 Woolhall Street, Bury St. Edmunds, Suffolk, IP33 1LA.

 

The company's principal activities and nature of its operations are disclosed in the Directors' Report.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006, including the provisions of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Vita Health Group Limited. These consolidated financial statements are available from its registered office, 14 Woolhall Street, Bury St. Edmunds, IP33 1LA.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

 

Crystal Palace Physio Holdings Limited is a wholly owned subsidiary of Vita Health Group Limited and the results of Crystal Palace Physio Holdings Limited are included in the consolidated financial statements of Vita Health Group Limited which are available from First Floor Premises, 14 Woolhall Street, Bury St. Edmunds, IP33 1LA.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for a period of at least 12 month from the date of approval of these financial statements.

 

Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 12 -
1.3
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the current tax expense and deferred tax expense. Current tax assets are recognised when tax paid exceeds the tax payable.

 

Current and deferred tax is charged or credited to profit or loss, except when it relates to items charged or credited to other comprehensive income or equity, when the tax follows the transaction or event it relates to and is also charged or credited to other comprehensive income, or equity.

 

Current tax assets and current tax liabilities and deferred tax assets and deferred tax liabilities are offset, if and only if, there is a legally enforceable right to set off the amounts and the entity intends either to settle on the net basis or to realise the asset and settle the liability simultaneously.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
2
Judgements and key sources of estimation uncertainty
(Continued)
- 13 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Fixed asset investments

Assessing whether or not investments in subsidiary entities remain unimpaired requires the exercising of judgement, particularly during a period of change in the underlying business and as a strategy of growth and performance improvement is pursued. In undertaking this assessment directors have regards to estimates of future profitability, discount rates and/or multiples of value that might be realised on sale. Each of these elements is subject to estimation uncertainty that may be subject to future revision and such uncertainty is heightened by the relatively early stage of the company's development in its present form. Having undertaken a review as at 31st December 2022 the directors do not consider that any material impairment has arisen.

3
Auditor's remuneration

The audit fees for the year and the prior year have been borne by the parent company Vita Health Group Limited.

4
Employees

The company has no employees, other than directors who did not receive any remuneration (2021:£Nil)

5
Fixed asset investments
2022
2021
Notes
£
£
Investments in subsidiaries
6
1,736,278
1,736,278
6
Subsidiaries

Details of the company's subsidiaries at 31 December 2022 are as follows:

Name of undertaking
Address
Nature of business
Class of
% Held
shares held
Direct
Vita Health Solutions Limited
1
Physiotherapy and mental health services
Ordinary
100.00

Registered office addresses (all UK unless otherwise indicated):

1
First Floor Premises, 14 Woolhall Street, Bury St. Edmunds, IP33 1LA
7
Debtors
2022
2021
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
53,712
53,712
CRYSTAL PALACE PHYSIO HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 14 -
8
Share capital
2022
2021
2022
2021
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
108,340
108,340
1,083
1,083

The company's ordinary shares, which carry no right to fixed income , each carry the right to one vote at general meetings of the company.

9
Financial commitments, guarantees and contingent liabilities

The company is part to a debenture in favour of Shawbrook Bank Limited in respect of borrowings of it's immediate parent company Vita Health Group Limited a fixed and floating charge over all assets of the company.

10
Ultimate controlling party

The company's immediate parent company as at 31 December 2022 was Vita Health Group Limited.

 

The company's ultimate parent company as at 31 December 2022 was Kingfisher Topco Limited.

 

The smallest group in which the results of the company are consolidated is that headed by Vita Health Group Limited. The consolidated accounts of Vita Health Group Limited are available from its registered office First Floor Premises, 14 Woolhall Street, Bury St. Edmunds, IP33 1LA.

 

The largest group in which the results of the company are consolidated is that headed by Kingfisher Topco Limited. The consolidated accounts of Kingfisher Topco Limited are available from its registered office First Floor Premises, 14 Woolhall Street, Bury St. Edmunds, IP33 1LA.

2022-12-312022-01-01falseCCH SoftwareCCH Accounts Production 2023.100Mr D M FarrellMr S J FosterMr J P Clover94643082022-01-012022-12-319464308bus:Director12022-01-012022-12-319464308bus:Director22022-01-012022-12-319464308bus:Director32022-01-012022-12-319464308bus:RegisteredOffice2022-01-012022-12-3194643082022-12-3194643082021-01-012021-12-319464308core:RetainedEarningsAccumulatedLosses2021-01-012021-12-319464308core:RetainedEarningsAccumulatedLosses2022-01-012022-12-3194643082021-12-319464308core:ShareCapital2022-12-319464308core:ShareCapital2021-12-319464308core:SharePremium2022-12-319464308core:SharePremium2021-12-319464308core:CapitalRedemptionReserve2022-12-319464308core:CapitalRedemptionReserve2021-12-319464308core:RetainedEarningsAccumulatedLosses2022-12-319464308core:RetainedEarningsAccumulatedLosses2021-12-319464308core:ShareCapital2020-12-319464308core:SharePremium2020-12-319464308core:CapitalRedemptionReservecore:RestatedAmount2020-12-319464308core:RetainedEarningsAccumulatedLosses2020-12-319464308core:Non-currentFinancialInstruments2022-12-319464308core:Non-currentFinancialInstruments2021-12-319464308core:Subsidiary12022-01-012022-12-319464308core:Subsidiary112022-01-012022-12-319464308core:CurrentFinancialInstruments2022-12-319464308core:CurrentFinancialInstruments2021-12-319464308bus:PrivateLimitedCompanyLtd2022-01-012022-12-319464308bus:FRS1022022-01-012022-12-319464308bus:Audited2022-01-012022-12-319464308bus:FullAccounts2022-01-012022-12-31xbrli:purexbrli:sharesiso4217:GBP